165 related articles for article (PubMed ID: 8096511)
1. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
Schinkel AH; Kemp S; Dollé M; Rudenko G; Wagenaar E
J Biol Chem; 1993 Apr; 268(10):7474-81. PubMed ID: 8096511
[TBL] [Abstract][Full Text] [Related]
2. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein.
Schinkel AH; Arceci RJ; Smit JJ; Wagenaar E; Baas F; Dollé M; Tsuruo T; Mechetner EB; Roninson IB; Borst P
Int J Cancer; 1993 Sep; 55(3):478-84. PubMed ID: 8104165
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
[TBL] [Abstract][Full Text] [Related]
4. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
Choi KH; Chen CJ; Kriegler M; Roninson IB
Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
[TBL] [Abstract][Full Text] [Related]
5. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
Azzaria M; Schurr E; Gros P
Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
[TBL] [Abstract][Full Text] [Related]
6. Sequence of mdr3 cDNA encoding a human P-glycoprotein.
van der Bliek AM; Kooiman PM; Schneider C; Borst P
Gene; 1988 Nov; 71(2):401-11. PubMed ID: 2906314
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.
Kioka N; Tsubota J; Kakehi Y; Komano T; Gottesman MM; Pastan I; Ueda K
Biochem Biophys Res Commun; 1989 Jul; 162(1):224-31. PubMed ID: 2568832
[TBL] [Abstract][Full Text] [Related]
12. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells.
Richert ND; Aldwin L; Nitecki D; Gottesman MM; Pastan I
Biochemistry; 1988 Oct; 27(20):7607-13. PubMed ID: 2905169
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.
Gros P; Dhir R; Croop J; Talbot F
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7289-93. PubMed ID: 1678520
[TBL] [Abstract][Full Text] [Related]
14. mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles.
Gekeler V; Weger S; Probst H
Biochem Biophys Res Commun; 1990 Jun; 169(2):796-802. PubMed ID: 1972623
[TBL] [Abstract][Full Text] [Related]
15. The multidrug resistance (mdr1) gene product functions as an ATP channel.
Abraham EH; Prat AG; Gerweck L; Seneveratne T; Arceci RJ; Kramer R; Guidotti G; Cantiello HF
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):312-6. PubMed ID: 7678345
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
Schinkel AH; Roelofs EM; Borst P
Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles.
Dhir R; Gros P
Biochemistry; 1992 Jul; 31(26):6103-10. PubMed ID: 1352702
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of human MDR1 mRNA by a hammerhead ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
FEBS Lett; 1993 Mar; 319(1-2):71-4. PubMed ID: 8095909
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance.
Papadopoulou B; Roy G; Dey S; Rosen BP; Ouellette M
J Biol Chem; 1994 Apr; 269(16):11980-6. PubMed ID: 7909316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
